144 ·Filed Jun 16, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
No material signal from this routine tax-withholding sale. Monitor for any future discretionary insider sales or changes in insider ownership patterns.
Final — all horizons settled through T+60d ⚠ clustered
TARS ▲ +26.79% at T+60d
NEUTRAL call ✓ call won +26.79% · α vs SPY +23.65% · entry $62.55 → $79.31
T+1d
+0.98%
call +0.98% · α +0.20%
$63.16
settled 4mo ago
T+5d
+7.29%
call +7.29% · α +8.33%
$67.11
settled 3mo ago
T+20d
-7.77%
call -7.77% · α -9.09%
$57.69
settled 3mo ago
T+60d
+26.79%
call +26.79% · α +23.65%
$79.31
settled 21d ago
Price Chart
Loading chart...
Executive Summary
Officer Jeffrey S. Farrow filed a Form 144 to sell 14,396 shares of Tarsus Pharmaceuticals common stock, valued at approximately $877K, to cover tax obligations from restricted stock vesting. This is a routine sell-to-cover transaction, not a discretionary sale, and carries no bearish signal.
Key Facts
- Insider Jeffrey S. Farrow (Officer) filed Form 144 to sell 14,396 shares.
- Estimated sale value: $877,459.23 based on a price of ~$60.96/share.
- Shares originate from restricted stock vesting on June 15, 2026.
- Sale is to cover tax withholding obligations, not a discretionary cash-out.
- Prior small sales in March 2026 were also tax-related (2,111–2,186 shares each).
- Sale represents ~0.03% of TARS's $2.7B market cap — immaterial.
Financial Impact
~$877K sale, 0.03% of market cap, tax-motivated
dilutioninsider holdings
Risk Factors
- None directly from this filing; routine insider transaction.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (15 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004721 |
| Document: 0001959173-26-004721-index.html | 0001959173-26-004721 |
| Document: 0001959173-26-004721.txt | 0001959173-26-004721 |
13 reports for TARS
100% Hit rate best @ T+20▲ +27.36%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $82.77 $77.64 | ▼ −6.20% | ▼ −5.54% | $73.00 (−11.80%) |
Sep 3, 2026 29d ago | Insider Cluster | $83.21 $79.31 | ▼ −4.68% | ▼ −3.53% | $73.00 (−12.26%) |
Sep 2, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.00 (+11.79%) |
Sep 1, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.00 (+11.79%) |
Aug 19, 2026 6w ago | 144 | $73.44 $70.65 | ▼ −3.80% | ▼ −3.41% | $73.00 (−0.60%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Mon (64h 7m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access